Ignite Creation Date:
2024-05-06 @ 7:14 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02497508
Status:
COMPLETED
Last Update Posted:
2017-09-14
First Post:
2015-07-06
Brief Title:
Nivolumab in Patients With Recurrent Malignant Mesothelioma
Sponsor:
The Netherlands Cancer Institute
Organization:
The Netherlands Cancer Institute
Organization Data
Organization:
The Netherlands Cancer Institute
Class:
OTHER
Study ID:
N14MPN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Netherlands Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |